Enhanced Algorithm for Crohn's Treatment Incorporating Early Combination Therapy (REACT2)
A Cluster Randomized Controlled Trial of an Enhanced Treatment Algorithm for the Management of Crohn's Disease
Sponsor: Alimentiv Inc.
A PHASE4 clinical study on Crohn's Disease, this trial is completed. The trial is conducted by Alimentiv Inc. and has accumulated 13 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Dec 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Oct 2021 — Dec 2021 [monthly]
Completed PHASE4
▶ Show 8 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Completed PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
May 2019 — Dec 2020 [monthly]
Active Not Recruiting PHASE4
-
Nov 2018 — May 2019 [monthly]
Active Not Recruiting PHASE4
Status: Enrolling By Invitation → Active Not Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Enrolling By Invitation PHASE4
-
Aug 2017 — Jun 2018 [monthly]
Enrolling By Invitation PHASE4
Status: Unknown Status → Enrolling By Invitation
-
Jul 2017 — Aug 2017 [monthly]
Unknown Status PHASE4
Status: Enrolling By Invitation → Unknown Status
-
Jan 2017 — Jul 2017 [monthly]
Enrolling By Invitation PHASE4
First recorded
Mar 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alimentiv Inc.
For direct contact, visit the study record on ClinicalTrials.gov .